✦ LIBER ✦

Trends of bevacizumab use and toxicity in advanced ovarian cancer over the last 7 years: A multi-institutional study

✍ Scribed by J. Chapman; K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; M. Polin; A. ElNaggar; J. Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors predictive of toxicity associate

✍ J. Chan; W. Huh; C. McClung; A. Alvarez-Secord; K. Moore; R. Previs; L. Perry; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 111 KB

The efficacy and safety of chemotherapy

✍ K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Population-based study of ovarian cancer

✍ Zeinab Hamidou; Sylvain Causeret; Tienhan S Dabakuyo; Julie Gentil; Laurent Arno 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 282 KB

Physical symptoms, coping styles and qua

✍ Price, M.A.; Bell, M.L.; Sommeijer, D.W.; Friedlander, M.; Stockler, M.R.; deFaz 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 523 KB

Re: “Cytoreductive surgery and hyperther

✍ Luca Ansaloni; Pierandrea De Iaco; Luigi Frigerio 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB